Search research articles
Contact Us
Filters
Showing results (401-410 of 663) with videos related to
Page
of 67
Sort By:
The Journal of Infectious Diseases
|
April 2, 2016
Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa
Andrew N Phillips, Valentina Cambiano, Paul Revill, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 25, 2002
A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy
Steven G Deeks, Bridget Wagner, Peter A Anton, et al.
The Journal of Infectious Diseases
|
March 16, 2011
A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response
Hiroyu Hatano, Timothy L Hayes, Viktor Dahl, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 21, 2021
SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency
Saki Takahashi, Michael J Peluso, Jill Hakim, et al.
Plos Pathogens
|
July 15, 2016
CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART
Rémi Fromentin, Wendy Bakeman, Mariam B Lawani, et al.
Journal of Virology
|
October 24, 2008
Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy
Hiroyu Hatano, Eric L Delwart, Philip J Norris, et al.
Journal of Virus Eradication
|
March 17, 2020
Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1
Michael J Peluso, Cassandra Thanh, Cecilia A Prator, et al.
Blood Advances
|
December 12, 2018
Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma
Chia-Ching Wang, Cassandra Thanh, Erica A Gibson, et al.
Life Science Alliance
|
July 14, 2025
In vivo detection of antisense HIV-1 transcripts in untreated and ART-treated individuals
Adam A Capoferri, Rachel Sklutuis, Toluleke O Famuyiwa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 17, 2013
A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy
Adam M Spivak, Adriana Andrade, Evelyn Eisele, et al.
Page
of 67
Search research articles
Search
Showing results (401-410 of 663) with videos related to
Sort By:
Page
of 67
The Journal of Infectious Diseases
|
April 2, 2016
Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa
Andrew N Phillips, Valentina Cambiano, Paul Revill, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 25, 2002
A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy
Steven G Deeks, Bridget Wagner, Peter A Anton, et al.
The Journal of Infectious Diseases
|
March 16, 2011
A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response
Hiroyu Hatano, Timothy L Hayes, Viktor Dahl, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 21, 2021
SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency
Saki Takahashi, Michael J Peluso, Jill Hakim, et al.
Plos Pathogens
|
July 15, 2016
CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART
Rémi Fromentin, Wendy Bakeman, Mariam B Lawani, et al.
Journal of Virology
|
October 24, 2008
Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy
Hiroyu Hatano, Eric L Delwart, Philip J Norris, et al.
Journal of Virus Eradication
|
March 17, 2020
Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1
Michael J Peluso, Cassandra Thanh, Cecilia A Prator, et al.
Blood Advances
|
December 12, 2018
Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma
Chia-Ching Wang, Cassandra Thanh, Erica A Gibson, et al.
Life Science Alliance
|
July 14, 2025
In vivo detection of antisense HIV-1 transcripts in untreated and ART-treated individuals
Adam A Capoferri, Rachel Sklutuis, Toluleke O Famuyiwa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 17, 2013
A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy
Adam M Spivak, Adriana Andrade, Evelyn Eisele, et al.
Page
of 67